Yang C, Zhang S, Zhang R, Zhao Y, Yang D, Yang M
World J Gastrointest Surg. 2025; 17(2):102342.
PMID: 40061979
PMC: 11885995.
DOI: 10.4240/wjgs.v17.i2.102342.
Chia S, Guo T, Goldys E, Payne S, Duan W, Lovell N
Bioeng Transl Med. 2025; 10(2):e10725.
PMID: 40060765
PMC: 11883116.
DOI: 10.1002/btm2.10725.
Shin S, Chen S, Xie K, Duhun S, Ortiz-Cerda T
Redox Rep. 2025; 30(1):2471737.
PMID: 40056427
PMC: 11892051.
DOI: 10.1080/13510002.2025.2471737.
Wang S, Wang X, Ding J, Zhang X, Zhu H, Fan Y
Front Pharmacol. 2025; 16:1436183.
PMID: 40008128
PMC: 11851071.
DOI: 10.3389/fphar.2025.1436183.
Zhu Y, Chen Y, Tang Y, Zhang X, Shen Q, Li F
Front Psychol. 2025; 16:1483021.
PMID: 39973951
PMC: 11836826.
DOI: 10.3389/fpsyg.2025.1483021.
RISE-MX, a real-world study of patients with moderate/severe inflammatory bowel disease returning for hospital follow-up in Mexico: baseline demographics and clinical characteristics, treatment and disease status.
Martinez-Vazquez M, Bosques-Padilla F, Miranda-Cordero R, Yamamoto-Furusho J
Therap Adv Gastroenterol. 2025; 18:17562848251318857.
PMID: 39968532
PMC: 11833814.
DOI: 10.1177/17562848251318857.
Histone deacetylase in inflammatory bowel disease: novel insights.
Li C, Gu S, Zhang Y, Zhang Z, Wang J, Gao T
Therap Adv Gastroenterol. 2025; 18:17562848251318833.
PMID: 39963253
PMC: 11831641.
DOI: 10.1177/17562848251318833.
LncRNA regulates the inflammatory response in inflammatory bowel disease targeting the miR-23a-3p/ axis.
Tong F, Wang R, Wei Z, Xu S
Cent Eur J Immunol. 2025; 49(4):332-344.
PMID: 39944256
PMC: 11811720.
DOI: 10.5114/ceji.2024.145007.
EGCG Alleviates DSS-Induced Colitis by Inhibiting Ferroptosis Through the Activation of the Nrf2-GPX4 Pathway and Enhancing Iron Metabolism.
Chen J, Yin C, Zhang Y, Lai X, Liu C, Luo Y
Nutrients. 2025; 17(3).
PMID: 39940407
PMC: 11820173.
DOI: 10.3390/nu17030547.
Identification of ubiquitination-related key biomarkers and immune infiltration in Crohn's disease by bioinformatics analysis and machine learning.
Chen W, Xu Z, Sun H, Feng W, Huang Z
Sci Rep. 2025; 15(1):3444.
PMID: 39870856
PMC: 11772853.
DOI: 10.1038/s41598-025-88148-4.
Therapeutic Potential of (L.) . Leaf Extract in Modulating Gut Microbiota and Immune Response for the Treatment of Inflammatory Bowel Disease.
Lin M, Piao L, Zhao Z, Liao L, Wang D, Zhang H
Pharmaceuticals (Basel). 2025; 18(1.
PMID: 39861130
PMC: 11769518.
DOI: 10.3390/ph18010067.
Methyl 3-Bromo-4,5-dihydroxybenzoate Attenuates Inflammatory Bowel Disease by Regulating TLR/NF-κB Pathways.
Huang J, Li L, Xu L, Feng L, Wang Y, Sik A
Mar Drugs. 2025; 23(1).
PMID: 39852549
PMC: 11766471.
DOI: 10.3390/md23010047.
CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity.
Kong Y, Li J, Zhao X, Wu Y, Chen L
Front Immunol. 2025; 15():1519671.
PMID: 39850899
PMC: 11754230.
DOI: 10.3389/fimmu.2024.1519671.
Diagnosis and management of inflammatory bowel disease after solid organ transplantation in the era of biologic therapy: a case series.
Johnson Jr W, Vaughn B, Lim N
Front Transplant. 2025; 3():1483943.
PMID: 39846032
PMC: 11751014.
DOI: 10.3389/frtra.2024.1483943.
Impact of pericarditis on cardiovascular complications and healthcare utilization in patients with inflammatory bowel disease: a National Inpatient Sample study.
Garg A, Menon R, Brar A, Chaudhary H, Sohal A, Kaur A
Ann Gastroenterol. 2025; 38(1):51-59.
PMID: 39802295
PMC: 11724386.
DOI: 10.20524/aog.2024.0931.
A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases.
Khoon L, Piran R
Int J Mol Sci. 2025; 26(1.
PMID: 39796264
PMC: 11722080.
DOI: 10.3390/ijms26010410.
Interplay of Transcriptomic Regulation, Microbiota, and Signaling Pathways in Lung and Gut Inflammation-Induced Tumorigenesis.
Otalora-Otalora B, Payan-Gomez C, Lopez-Rivera J, Pedroza-Aconcha N, Arboleda-Mojica S, Aristizabal-Guzman C
Cells. 2025; 14(1.
PMID: 39791702
PMC: 11720097.
DOI: 10.3390/cells14010001.
Crohn's disease, irritable bowel syndrome, and chronic fatigue: the importance of communication and symptom management-a case report.
Haedrich J, Huber R
J Med Case Rep. 2025; 19(1):9.
PMID: 39789666
PMC: 11721286.
DOI: 10.1186/s13256-024-05010-3.
The Effect of the Size of Gold Nanoparticle Contrast Agents on CT Imaging of the Gastrointestinal Tract and Inflammatory Bowel Disease.
Rosario-Berrios D, Pang A, Liu L, Maidment P, Kim J, Yoon S
Bioconjug Chem. 2025; 36(2):233-244.
PMID: 39786354
PMC: 11839313.
DOI: 10.1021/acs.bioconjchem.4c00507.
Developing and evaluating a gamified self-management application for inflammatory bowel disease using the ADDIE model and Sukr framework.
Norouzkhani N, Norouzi S, Faramarzi M, Bahari A, Shirvani J, Eslami S
BMC Med Inform Decis Mak. 2025; 25(1):11.
PMID: 39780171
PMC: 11715334.
DOI: 10.1186/s12911-024-02842-3.